• Revenue Cycle Management
  • COVID-19
  • Reimbursement
  • Diabetes Awareness Month
  • Risk Management
  • Patient Retention
  • Staffing
  • Medical Economics® 100th Anniversary
  • Coding and documentation
  • Business of Endocrinology
  • Telehealth
  • Physicians Financial News
  • Cybersecurity
  • Cardiovascular Clinical Consult
  • Locum Tenens, brought to you by LocumLife®
  • Weight Management
  • Business of Women's Health
  • Practice Efficiency
  • Finance and Wealth
  • EHRs
  • Remote Patient Monitoring
  • Sponsored Webinars
  • Medical Technology
  • Billing and collections
  • Acute Pain Management
  • Exclusive Content
  • Value-based Care
  • Business of Pediatrics
  • Concierge Medicine 2.0 by Castle Connolly Private Health Partners
  • Practice Growth
  • Concierge Medicine
  • Business of Cardiology
  • Implementing the Topcon Ocular Telehealth Platform
  • Malpractice
  • Influenza
  • Sexual Health
  • Chronic Conditions
  • Technology
  • Legal and Policy
  • Money
  • Opinion
  • Vaccines
  • Practice Management
  • Patient Relations
  • Careers

Poor Earnings Season Worsens With Apple's Miss


This earnings seasons has been mostly a disappointment despite the fact a majority of companies beat estimates, because there's something else going on.

If investors were hoping Apple, Inc. would inject this earnings season with a little jolt, they were sorely disappointed when the company missed estimates in a rare bad show. Now it’s looking like nothing can help this earnings season.

The Wall Street Journal

Even though the news from earnings season looks good at first glance, it’s covering up some bad news. So far a quarter of companies have reported and roughly two-thirds have beat expectations. However, S&P 500 companies are still on track for profits to decline by 1% over last year, according to .


The reason why so many companies are meeting or surpassing estimates and, yet, are still on target for a profit decline, is because estimates are lower than usual. The market has been living off the relief resulting when companies are meeting those estimates, according to .


Basically, the sentiment in the market is that things aren’t looking impressive, but they aren’t bad as initially feared, according to . However, the disappointing growth in revenue should be concerning for investors.

And now even Apple has missed its estimates, causing the stock to plunge by 4.32%, or $25.95, throughout the day to close at $574.97. Typically, Apple is relied upon to blow out expectations. Even though Apple’s reported revenue of $35 billion, up 23% year-over-year, analysts expected revenue of $37.2 billion.

Apple stock at the end of the day on July 25, 2012.

Apple’s reason for the unexpected miss was that the company sold less iPhones, perhaps because consumers are waiting for the newest version that is rumored to come out in the fall.

Read more:

Earnings Season’s Nasty Little Secret

Earnings Reports Kick into High Gear: 4 Stocks to Watch

Related Videos
Victor J. Dzau, MD, gives expert advice
Victor J. Dzau, MD, gives expert advice